Published in Trans Assoc Am Physicians on January 01, 1976
Uncompensated polyuria in a mouse model of Bartter's syndrome. Proc Natl Acad Sci U S A (2000) 1.59
Studies on the clinical pharmacology of prazosin. II: The influence of indomethacin and of propranolol on the action and disposition of prazosin. Br J Clin Pharmacol (1980) 0.96
Prostacyclin produced by the pregnant uterus in the dog may act as a circulating vasodepressor substance. J Clin Invest (1981) 0.93
Bartter's syndrome--the case for a primary potassium-losing tubulopathy: discussion paper. J R Soc Med (1983) 0.88
Intracellular granules of the renal medulla in a case of potassium depletion due to renal potassium wasting. Electron microscopic comparison with renal medullary granules in the potassium-depleted rat. Am J Pathol (1978) 0.82
Flurbiprofen interaction with single doses of atenolol and propranolol. Br J Clin Pharmacol (1984) 0.82
Eicosanoids and tumor necrosis factor-alpha in the kidney. Prostaglandins Other Lipid Mediat (2011) 0.76
Nephrocalcinosis and placental findings in neonatal bartter syndrome. AJP Rep (2012) 0.75
Plasma propranolol levels in adults with observations in four children. Clin Pharmacol Ther (1970) 9.54
Survey of unlicensed and off label drug use in paediatric wards in European countries. European Network for Drug Investigation in Children. BMJ (2000) 8.10
The syndrome of inappropriate secretion of antidiuretic hormone. Am J Med (1967) 8.08
Liddle's syndrome: heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel. Cell (1994) 5.29
Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med (1995) 3.91
Evidence for a phosphorus-depletion syndrome in man. N Engl J Med (1968) 3.34
Histopathology of benign versus malignant sympathoadrenal paragangliomas: clinicopathologic study of 120 cases including unusual histologic features. Hum Pathol (1990) 3.22
Urinary prostaglandins. Identification and origin. J Clin Invest (1975) 3.07
Closing the gap in drug therapy. Lancet (1999) 3.01
Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase. Clin Chem (1986) 2.95
Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE. J Immunol (1982) 2.69
The relative efficacy of guanethidine, methyldopa and pargyline as antihypertensive agents. N Engl J Med (1965) 2.64
Prostaglandins as mediators of hypercalcemia associated with certain types of cancer. N Engl J Med (1975) 2.63
Effects of caffeine on plasma renin activity, catecholamines and blood pressure. N Engl J Med (1978) 2.50
Coronary arterial smooth muscle contraction by a substance released from platelets: evidence that it is thromboxane A2. Science (1976) 2.39
Clinical experience over 48 years with pheochromocytoma. Ann Surg (1999) 2.32
Guanethidine and related agents. 3. Antagonism by drugs which inhibit the norepinephrine pump in man. J Clin Invest (1970) 2.29
Salt-sensitive hypertension and reduced fertility in mice lacking the prostaglandin EP2 receptor. Nat Med (1999) 2.26
Mac-1 (CD11b/CD18) mediates adherence-dependent hydrogen peroxide production by human and canine neutrophils. J Immunol (1990) 2.24
Retinal hemorrhages caused by accidental household trauma. J Pediatr (1999) 2.22
Estimated rate of prostacyclin secretion into the circulation of normal man. J Clin Invest (1981) 2.18
Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man. J Clin Invest (1983) 2.13
The effect of high-sodium and low-sodium intakes on blood pressure and other related variables in human subjects with idiopathic hypertension. Am J Med (1978) 2.05
Insulin release by isolated pancreatic islets of the mouse incubated in vitro. Diabetologia (1969) 2.04
Release of prostaglandin D2 into human airways during acute antigen challenge. N Engl J Med (1986) 2.03
Tolerance to the humoral and hemodynamic effects of caffeine in man. J Clin Invest (1981) 2.03
Mutations in the Na-Cl cotransporter reduce blood pressure in humans. Hypertension (2001) 1.99
Reduction of renal function by newer nonsteroidal anti-inflammatory drugs. Am J Med (1978) 1.96
von Recklinghausen's disease and pheochromocytomas. J Urol (1999) 1.92
Inflammation in the course of early myocardial ischemia. FASEB J (1991) 1.90
Comparative assessment of stimuli that release neuronal and adrenomedullary catecholamines in man. Circulation (1979) 1.88
Continuous measurement of tissue blood flow by laser-Doppler spectroscopy. Am J Physiol (1977) 1.82
Ionophores stimulate prostaglandin and thromboxane biosynthesis. Proc Natl Acad Sci U S A (1977) 1.82
Increased incidence of isoniazid hepatitis in rapid acetylators: possible relation to hydranize metabolites. Clin Pharmacol Ther (1975) 1.75
Pharmacologic and endocrine aspects of carcinoid syndrome. Adv Pharmacol (1967) 1.74
Tissue and subcellular localization of enzymes of arginine metabolism in Pisum sativum. Biochem Biophys Res Commun (1981) 1.69
Muscle Changes in Denervation and Re-innervation. Br Med J (1945) 1.69
Decreased taste sensitivity after D-penicillamine reversed by copper administration. Lancet (1967) 1.69
Antagonism of the antihypertensive action of guanethidine sulfate by desipramine hydrochloride. JAMA (1967) 1.67
Distinction between hyperaldosteronism due to bilateral hyperplasia and unilateral aldosteronoma: reliability of CT. Radiology (1992) 1.66
Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2. N Engl J Med (1999) 1.65
Iodine-131-metaiodobenzylguanidine scintigraphy in preoperative and postoperative evaluation of paragangliomas: comparison with CT and MRI. J Nucl Med (1993) 1.65
Sipple's syndrome: medullary thyroid carcinoma, pheochromocytoma, and parathyroid disease. Studies in a large family. NIH conference. Ann Intern Med (1973) 1.64
Plasma metanephrines in the diagnosis of pheochromocytoma. Ann Intern Med (1995) 1.64
Increased production of prostaglandin D2 in patients with systemic mastocytosis. N Engl J Med (1980) 1.63
Suppression of plasma renin activity by indomethacin in man. Circ Res (1976) 1.62
Plasma binding and the affinity of propranolol for a beta receptor in man. Clin Pharmacol Ther (1976) 1.62
[Studies of the effect of the diuretics furosemide, ethacrynic acid and triamterene on renal magnesium and calcium excretion]. Klin Wochenschr (1967) 1.61
Modulation of human neutrophil function by monohydroxy-eicosatetraenoic acids. Immunology (1980) 1.60
Simultaneous analysis of dapsone and monoacetyldapsone employing high performance liquid chromatography: a rapid method for determination of acetylator phenotype. Br J Clin Pharmacol (1978) 1.57
STUDIES ON TASTE THRESHOLDS IN NORMAL MAN AND IN PATIENTS WITH ADRENAL CORTICAL INSUFFICIENCY: THE ROLE OF ADRENAL CORTICAL STEROIDS AND OF SERUM SODIUM CONCENTRATION. J Clin Invest (1963) 1.56
Treatment with thyrocalcitonin of the hypercalcemia of parathyroid carcinoma. J Clin Endocrinol Metab (1968) 1.55
Hereditary hypertension caused by chimaeric gene duplications and ectopic expression of aldosterone synthase. Nat Genet (1992) 1.55
Validity and reliability of liquid chromatography with electrochemical detection for measuring plasma levels of norepinephrine and epinephrine in man. Life Sci (1981) 1.55
Bartter's syndrome: a disorder characterized by high urinary prostaglandins and a dependence of hyperreninemia on prostaglandin synthesis. Am J Med (1976) 1.55
Effect of oral prednisone on airway inflammatory mediators in atopic asthma. Am J Respir Crit Care Med (1994) 1.54
Effects of polymerization on the hypertensive action of diaspirin cross-linked hemoglobin in rats. J Lab Clin Med (1997) 1.52
Prostaglandin biosynthesis by rabbit renomedullary interstitial cells in tissue culture. Stimulation by angiotensin II, bradykinin, and arginine vasopressin. J Clin Invest (1977) 1.50
Proposed mechanisms of propranolol's antihypertensive effect in essential hypertension. N Engl J Med (1976) 1.47
Determination of metanephrines in plasma by liquid chromatography with electrochemical detection. Clin Chem (1993) 1.47
Nephrogenous cyclic adenosine monophosphate as a parathyroid function test. J Clin Invest (1977) 1.47
Endothelium-dependent hyperpolarization caused by bradykinin in human coronary arteries. J Clin Invest (1993) 1.46
Human amyloid protein: chemical variability and homogeneity. J Histochem Cytochem (1971) 1.45
Thiazide diuretics, hypokalemia and cardiac arrhythmias. Acta Med Scand Suppl (1981) 1.45
Chlorpromazine reversal of the antihypertensive action of guanethidine. Lancet (1971) 1.43
Hypertension and fibromuscular dysplasia of the renal arteries. Surgery (1969) 1.42
Neutrophil induced oxidative injury of cardiac myocytes. A compartmented system requiring CD11b/CD18-ICAM-1 adherence. J Clin Invest (1992) 1.42
Plasma dihydroxyphenylglycol and the intraneuronal disposition of norepinephrine in humans. J Clin Invest (1988) 1.41
Inhibition of monoamine oxidase in man by furazolidone. Clin Pharmacol Ther (1968) 1.40
(R)-Profens are substrate-selective inhibitors of endocannabinoid oxygenation by COX-2. Nat Chem Biol (2011) 1.39
Prostaglandin thromboxane, and 12-hydroxy-5,8,10,14-eicosatetraenoic acid production by ionophore-stimulated rat serosal mast cells. Biochim Biophys Acta (1979) 1.39
Denatured muscle grafts for nerve repair. An experimental model of nerve damage in leprosy. J Bone Joint Surg Br (1990) 1.39
Collagen synthesis in human keloid and hypertrophic scar. Surg Forum (1971) 1.38
Inhibition of eicosanoid biosynthesis by glucocorticoids in humans. Proc Natl Acad Sci U S A (1990) 1.38
Effect of acetylator phenotype on the rate at which procainamide induces antinuclear antibodies and the lupus syndrome. N Engl J Med (1978) 1.37
Malignant pheochromocytoma: effective treatment with a combination of cyclophosphamide, vincristine, and dacarbazine. Ann Intern Med (1988) 1.37
Biosynthesis of prostaglandin D2. 1. Formation of prostaglandin D2 by human platelets. Prostaglandins (1977) 1.36
Metabolism of thromboxane B2 in man. Identification of twenty urinary metabolites. J Biol Chem (1981) 1.35
Quantification of the major urinary metabolite of 15-F2t-isoprostane (8-iso-PGF2alpha) by a stable isotope dilution mass spectrometric assay. Anal Biochem (1999) 1.34
Relation between plasma concentration of indomethacin and its effect on prostaglandin synthesis and platelet aggregation in man. Clin Pharmacol Ther (1978) 1.33
Elevated urinary prostaglandins and the effects of aspirin on renal function in lupus erythematosus. Ann Intern Med (1978) 1.33
Effects of dietary sodium and of acute saline infusion on the interrelationship between dopamine excretion and adrenergic activity in man. J Clin Invest (1974) 1.32
Blockade of the flush associated with metastatic gastric carcinoid by combined histamine H1 and H2 receptor antagonists. Evidence for an important role of H2 receptors in human vasculature. N Engl J Med (1979) 1.32
Urinary kallikrein excretion in hypertensive man. Relationships to sodium intake and sodium-retaining steroids. Circ Res (1974) 1.31
Sustained hypertension after section of the glossopharyngeal nerve. Am J Med (1977) 1.30